Cite
Cost‐effectiveness of treating all hepatitis B–positive individuals in the United States.
MLA
Razavi, Shearer, Devin, et al. “Cost‐effectiveness of Treating All Hepatitis B–positive Individuals in the United States.” Journal of Viral Hepatitis, vol. 30, no. 9, Sept. 2023, pp. 718–26. EBSCOhost, https://doi.org/10.1111/jvh.13843.
APA
Razavi, S. D., Estes, C., Gamkrelidze, I., & Razavi, H. (2023). Cost‐effectiveness of treating all hepatitis B–positive individuals in the United States. Journal of Viral Hepatitis, 30(9), 718–726. https://doi.org/10.1111/jvh.13843
Chicago
Razavi, Shearer, Devin, Chris Estes, Ivane Gamkrelidze, and Homie Razavi. 2023. “Cost‐effectiveness of Treating All Hepatitis B–positive Individuals in the United States.” Journal of Viral Hepatitis 30 (9): 718–26. doi:10.1111/jvh.13843.